July 2024 – Page 38 – Goldea Capital

California BanCorp Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024

Written by Customer Service on July 29, 2024. Posted in Earnings Releases And Operating Results.

OAKLAND, Calif., July 29, 2024 (GLOBE NEWSWIRE) — California BanCorp (NASDAQ: CALB) (the “Company”), whose subsidiary is California Bank of Commerce, announced today its financial results for the second quarter and six months ended June 30, 2024. The Company reported a net loss of $5.9 million for the second quarter of 2024, representing a decrease of $9.7 million, or 254%, compared to net income of $3.8 million for the first quarter of 2024 and a decrease of $11.3 million, or 208%, compared to $5.4 million in the second quarter of 2023. For the six months ended June 30, 2024, the Company reported a net loss of $2.0 million representing a decrease of $12.9 million, or 119%, compared to net income of $10.9 million for the same period in 2023. Diluted earnings per share of $(0.68) for the second quarter of 2024, compared to $0.45...

CBMJ Completes Audited Financials – Subsidiary Patriot.TV Positioned for Growth

Written by Customer Service on July 29, 2024. Posted in Public Companies.

VENICE, FL, July 29, 2024 (GLOBE NEWSWIRE) — Conservative Broadcast Media & Journalism (PINK:CBMJ) announced that it has completed PCAOB certified audits of its most recent two years of financials. The audits are consistent with and meet requirements for uplisting to senior exchanges. The company’s CEO Mark Schaftlein stated that “Providing audited financials and continually striving to exceed reporting requirements provides greater transparency, instills confidence, and is an important step in positioning the Company as it progresses towards a senior exchange. We are very proud of our compliance and accounting departments as they definitely delivered in meeting and exceeding all standards required to smoothly complete the third-party audit. We look forward to providing additional updates and milestones now that we have...

Arcutis Launches ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis

Written by Customer Service on July 29, 2024. Posted in Public Companies.

Once-daily, effective, safe, and well-tolerated ZORYVE cream now commercially available Provides rapid clearance of atopic dermatitis signs and symptoms and significant reduction in itch, and can be used anywhere on the body for any duration to maintain clear skin Atopic dermatitis is the most common type of eczema, affecting approximately 9.6 million children and 16.5 million adults in the United States Management will host an investor event with a key opinion leader on Monday, July 29 at 8:30 am EDT/5:30 am PDT WESTLAKE VILLAGE, Calif., July 29, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the commercial launch of ZORYVE® (roflumilast) cream 0.15% for the treatment of mild...

Glass House Brands Issues an Open Letter Urging President Biden, Former President Trump and Vice President Harris to De-Schedule Cannabis

Written by Customer Service on July 29, 2024. Posted in Public Companies.

LONG BEACH, Calif. and TORONTO, July 29, 2024 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company“) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., has issued an open letter to President Biden, Former President Trump and Vice President Harris urging them to completely de-schedule cannabis and to grant clemency to those incarcerated in federal prison for nonviolent marijuana offenses. Dear President Biden, Former President Trump and Vice President Harris, Our nation has spoken, and it wants federal cannabis laws to change. But, the people don’t just want cannabis rescheduling, they want complete de-scheduling. On July 22, 2024, the Drug Enforcement Administration’s (DEA) comment period...

Alaska Energy Metals Announces Advisory Committee Changes

Written by Customer Service on July 29, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) — Alaska Energy Metals Corporation (TSX-V: AEMC, OTCQB: AKEMF) (“Alaska Energy Metals”, the “Company”, or “AEMC”) today announced the reformulation of its Advisory Committee (the “Committee”). This strategic decision aligns with Alaska Energy Metals’ ongoing focus and determination to become a significant domestic source of critical and strategic energy-related metals for North America. Alaska Energy Metals President & CEO Gregory Beischer stated: “The new Committee has great depth in capital markets, finance, U.S. government policy, law, and magmatic nickel deposit geology. The Committee is a strong resource for the Company’s management team to draw upon. Paul Matysek will be instrumental with corporate introductions and executing on strategic partnerships, Clark...

Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada

Written by Customer Service on July 29, 2024. Posted in Public Companies.

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Bliss MAX system in Canada. The Venus Bliss MAX was first available in the United States in early 2022 and subsequently offered in approved jurisdictions around the world. The Venus Bliss MAX is a 3-in-1 body shaping solution featuring three of Venus Concept’s market leading technologies in one complete platform, including diode laser for Fat Reduction treatments, our proprietary (MP)2 applicator that combines Multi-Polar Radio Frequency with Pulsed Electro Magnetic Fields and advanced VariPulse™ technology for Cellulite Reduction and Skin treatments, and the Company’s...

Amesite Announces Dramatic Increase in NurseMagic™ Users, Representing All 50 States and 6 Nations, Using App for Wide Variety of Applications

Written by Customer Service on July 29, 2024. Posted in Public Companies.

NurseMagic™ Usage Ramping Quickly, with Nursing Professionals Accessing the App Multiple Times Per Week on Tasks Ranging from Documentation to Patient Care DETROIT, July 29, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced substantial growth in the user base of its app, NurseMagicTM, across all fifty (50) U.S. states and six (6) nations, within only eight (8) weeks of its public launch on June 5, following a period of availability as a gated beta product. NurseMagicTM is now delivering all key types of documentation, training and learning and support for patient communication, including translation services. Users now represent at least 27 different nursing and healthcare-related professions,...

Expanded Access Program Opens in the U.S. for TLX101-CDx, Telix’s Investigational Glioma (Brain Cancer) Imaging Agent

Written by Customer Service on July 29, 2024. Posted in Public Companies.

MELBOURNE, Australia, July 29, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the opening of an expanded access program (EAP) in the United States (U.S.) for TLX101-CDx (Pixclara™1, 18F-floretyrosine or 18F-FET) an investigational positron emission tomography (PET) agent for imaging progressive or recurrent glioma, following U.S. Food and Drug Administration (FDA) agreement to proceed. Amino acid PET is included in U.S. and European clinical practice guidelines for the imaging of gliomas2, however there is no FDA-approved targeted amino acid PET agent for brain cancer imaging currently available in the U.S. Telix’s goal is to make this product commercially available in the U.S., significantly increasing patient access to this important imaging agent for both adult...

Enstar Group Limited Reports Second Quarter 2024 Results

Written by Customer Service on July 29, 2024. Posted in Earnings Releases And Operating Results.

Enstar to be Acquired by Sixth Street-led Consortium for $5.1 Billion Net Income Attributable to Enstar Ordinary Shareholders of $126 Million; Return on Equity of 2.5% Primarily Driven by Positive Investment Results Year-to-Date Growth in Book Value per Ordinary Share of 4.5% to $358.74 (Fully Diluted* $350.74) Announced $400 Million Loss Portfolio Transfer with SiriusPoint Signed $350 Million Agreement to Provide Reinsurance Cover in Insurance-linked Securities (ILS) Market1 Entered into $200 Million Adverse Development Cover Agreement with Insurance Australia Group Closed $297 Million Transaction To Reinsure Legacy Business with Accredited1This transaction closed on July 25. * Non-GAAP measure; refer to “Non-GAAP Financial Measures” further below for explanatory notes and a reconciliation to the most directly comparable...

Enstar to be Acquired by Sixth Street for $5.1 Billion

Written by Customer Service on July 29, 2024. Posted in Mergers And Acquisitions.

Enstar shareholders to receive $338.00 per share in cash Strong alignment between Enstar and Sixth Street to ensure continuity of Enstar strategy HAMILTON, Bermuda, July 29, 2024 (GLOBE NEWSWIRE) — Enstar Group Limited (“Enstar”) (Nasdaq: ESGR) today announced that it has entered into a definitive merger agreement under which Sixth Street will acquire Enstar, with Liberty Strategic Capital, J.C. Flowers & Co. LLC, and other institutional investors participating in the transaction. Enstar shareholders will receive a total of $338.00 in cash per ordinary share of Enstar payable upon closing of the transaction, representing a total equity value of $5.1 billion. The consideration represents a premium of approximately 8.5% to the 90-day volume weighted average price (“VWAP”) of the company shares as of July 26, 2024, the last...

Month: July 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice